These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6993403)

  • 1. Clinical trial of droperidol for the determination of the neuroleptic threshold and the neuroleptic-therapeutic range.
    Haase HJ; Kaumeier S; Schwarz S; Gundel A; Linde OK; von Bomhard RH; Rauwolf ER; Scheel R; Seyfferth H; Stripf A; Stripf L
    Int Pharmacopsychiatry; 1980; 15(1):74-80. PubMed ID: 6993403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open study with bromperidol (C-C 2489), a new neuroleptic, for the determination of the neuroleptic threshold and the neuroleptic-therapeutic range.
    Haase HJ; Kaumeier S; Schwarz H; Gundel A; Linde OK; Maetz H; Scheel R; Stripf A; Stripf L
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):81-5. PubMed ID: 643910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of chloral hydrate and sodium amytal during clozapine initiation.
    Dickson RA; Williams R; Dalby JT
    Can J Psychiatry; 1994 Apr; 39(3):132-4. PubMed ID: 8033016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intensive neuroleptic treatment in schizophrenias].
    Pocher G; Schott G
    Psychiatr Neurol Med Psychol Beih; 1977; 22-23():171-4. PubMed ID: 122458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Droperidol in acutely agitated patients. A double-blind placebo-controlled study.
    van Leeuwen AM; Molders J; Sterkmans P; Mielants P; Martens C; Toussaint C; Hovent AM; Desseilles MF; Koch H; Devroye A; Parent M
    J Nerv Ment Dis; 1977 Apr; 164(4):280-3. PubMed ID: 321727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute responses of schizophrenic children to a sedative and a "stimulating" neuroleptic: a pharmacologic yardstick.
    Campbell M; Fish B; Shapiro T; Floyd A
    Curr Ther Res Clin Exp; 1972 Dec; 14(12):759-66. PubMed ID: 4629814
    [No Abstract]   [Full Text] [Related]  

  • 7. Haloperidol and droperidol treatment in schizophrenics. Clinical application of the "prolactin-model".
    Langer G; Pühringer W
    Acta Psychiatr Belg; 1980; 80(5):574-83. PubMed ID: 7234451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
    Kramer MS; Last B; Getson A; Reines SA
    Arch Gen Psychiatry; 1997 Jun; 54(6):567-72. PubMed ID: 9193198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute dystonia during fixed-dose neuroleptic treatment.
    Singh H; Levinson DF; Simpson GM; Lo ES; Friedman E
    J Clin Psychopharmacol; 1990 Dec; 10(6):389-96. PubMed ID: 2286708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroleptic hypothesis: study of the covariation of extrapyramidal and therapeutic drug effects.
    Alpert M; Diamond F; Weisenfreund J; Taleporos E; Friedhoff AJ
    Br J Psychiatry; 1978 Aug; 133():169-75. PubMed ID: 354734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advantages of the initial therapy of acute schizophrenia with large doses of droperidol/A comparative study (author's transl)].
    Weiser G; Tahedl A; Reisecker F; Meyer H
    Arzneimittelforschung; 1975 Nov; 25(11):1845-8. PubMed ID: 1243093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Droperidol vs. haloperidol in the initial management of acutely agitated patients.
    Resnick M; Burton BT
    J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsants as adjuncts for the neuroleptic treatment of schizophrenic psychoses: a clinical study with beclamide.
    Raptis C; Garcia-Borreguero D; Weber MM; Dose M; Bremer D; Emrich HM
    Acta Psychiatr Scand; 1990 Feb; 81(2):162-7. PubMed ID: 2183543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
    Lombertie ER; Durelle G; Fuseau A
    Ann Med Psychol (Paris); 1995 Oct; 153(8):531-4. PubMed ID: 8561400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiemetic efficacy of droperidol or metoclopramide combined with dexamethasone and diphenhydramine. Randomized open parallel study.
    Aapro MS; Froidevaux P; Roth A; Alberto P
    Oncology; 1991; 48(2):116-20. PubMed ID: 1997933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of droperidol in management of vestibular disorders.
    Johnson WH; Fenton RS; Evans A
    Laryngoscope; 1976 Jul; 86(7):946-54. PubMed ID: 778518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open trial of buspirone added to neuroleptics in schizophrenic patients.
    Goff DC; Midha KK; Brotman AW; McCormick S; Waites M; Amico ET
    J Clin Psychopharmacol; 1991 Jun; 11(3):193-7. PubMed ID: 2066458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication.
    Pugh CR; Steinert J; Priest RG
    Br J Psychiatry; 1983 Aug; 143():151-5. PubMed ID: 6137255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose.
    McEvoy JP; Hogarty GE; Steingard S
    Arch Gen Psychiatry; 1991 Aug; 48(8):739-45. PubMed ID: 1883257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous regional droperidol in the management of reflex sympathetic dystrophy: a double-blind, placebo-controlled, crossover study.
    Kettler RE; Abram SE
    Anesthesiology; 1988 Dec; 69(6):933-6. PubMed ID: 3057940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.